tirzepatide vs semaglutide benefits caused roughly half as many patients to stop treatment because of gastrointestinal side effects as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Tirzepatide vs. Semaglutide for Weight

In a study comparing tirzepatide with Semaglutide and a placebo, tirzepatide led to notable reductions in body weight and fat mass, primarily through decreased energy intake at meals

NICE guidance (NG28 for type 2 diabetes, TA875 for semaglutide 2.4 mg, and TA664 for liraglutide 3 mg) recommends regular monitoring of patients on GLP-1 therapy, with particular attention to tolerability and adverse effects

This study investigated the impact of ingesting a liposomal multivitamin and mineral (MVM) supplement compared to a non-liposomal MVM supplement on the appearance and clearance of vitamins and minerals in the bloodstream

metaphysis: G6pdh chon+ : n = 5, G6pdh chon : n = 7

3A), but the same did not occur with free testosterone levels (MD 1.62

Kanbay M, Copur S, Siriopol D, Yildiz AB, Gaipov A, van Raalte DH, et al